Chatterton & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Chatterton & Associates's JNJ Position: Q3 2026 in Review
Chatterton & Associates sold out of Johnson & Johnson (JNJ) in Q3 2026, closing a stake of 943 shares — an estimated $244K sold.
Chatterton & Associates first reported a position in JNJ in Q1 2026 and held it in 2 quarters. The position peaked at $244K in Q2 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Chatterton & Associates reported no remaining Johnson & Johnson position as of Q3 2026 after selling out during the quarter.
- Chatterton & Associates sold 943 Johnson & Johnson shares in Q3 2026, an estimated $244K.
- Chatterton & Associates first reported a position in Johnson & Johnson in Q1 2026 and held it in 2 quarters.
- Chatterton & Associates's Johnson & Johnson position peaked at $244K in Q2 2026.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Chatterton & Associates's 13F filing for Q3 2026, filed 12 Nov 2026.